Centene CNC Q1 2026 Earnings Massive EPS Beat Shocks Estimates Stock Rises 237 Kalaris Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid PreRevenue Biotech SSBI Q1 2026 Earnings Modest EPS of 025 as Bank Navigates Stable Environment PRU Q1 2026 Earnings Strong EPS Beat Drives Positive Sentiment Despite Modest Stock Dip ABUS Q1 2026 Earnings Wider Loss Than Expected as Biotech Reports No Revenue UNM Q1 2026 Earnings EPS Surpasses Estimates as Stock Finishes Flat